cb dc Featured

Enterprise IT Expenditure Survey: Google Cloud is expected to be the first choice for 50% of the respondents. Tae Kim, a science and technology columnist, wrote that according to a recent survey, Google Cloud has risen rapidly in the enterprise AI expenditure competition and may become the winner. According to the 2025 CIO survey released by Piper Sandler, 81 CIOs were asked about their budget priorities in different suppliers and technical fields. According to the survey, 87% of CIOs surveyed expect to increase the IT budget in 2025, which is the highest proportion of the survey since 2020. In this survey, the status of Google Cloud has risen significantly, surpassing Microsoft and OpenAI to become the "most strategic" AI supplier, with a support rate of 27%, a significant increase from 15% six months ago. Relatively speaking, Microsoft's support rate dropped from 33% to 24%. When asked which cloud company they plan to use to test or implement AI projects next year, 50% of the respondents chose Google Cloud, making it the top AI infrastructure provider. In addition, Harsh Kumar, a Piper semiconductor analyst, pointed out that these results are also beneficial to Invista, because all cloud companies are the main buyers of AI chips in NVIDIA. Kumar estimates that the entire AI chip market will have more than $500 billion in business opportunities by 2028.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).After the European Central Bank decided not to interest rates, the yield of euro zone government bonds changed little; The yield of German 10-year government bonds rose by 1 basis point to 2.14%.

There are 695 listed companies in Jiangsu Province. According to the latest statistics of Jiangsu Listed Companies Association, there were 695 listed companies in Jiangsu Province by the end of November, including 15 new companies this year. Among the 695 companies, there are 216 main boards of Shanghai Stock Exchange, 110 in science and technology innovation board, 126 main boards of Shenzhen Stock Exchange (including one pure B-share), 196 Growth Enterprise Market and 47 North Stock Exchange. By geographical distribution, the total number of listed companies in Suzhou is far ahead in the province, reaching 219, 124 in Nanjing, 123 in Wuxi and 72 in Changzhou. In terms of A-shares, as of the end of November, there were 694 A-share listed companies in Jiangsu Province with a total market value of 6,745.231 billion yuan, accounting for 12.92% and 7.80% of the corresponding total of A-share listed companies respectively.On December 11th, it was reported that the U.S. government was divided over the U.S. steel acquisition, and Biden considered blocking the transaction. It was reported that the U.S. Department of Defense, the Ministry of Finance and the State Council all believed that the Japanese Steel Company's $15 billion acquisition of American steel companies would not bring national security risks, but U.S. President Biden was expected to block the transaction. Earlier, some media quoted people familiar with the matter as saying that Biden planned to block the acquisition of American steel companies later this month on the grounds of national security. The Committee on Foreign Investment in the United States has been reviewing the proposed acquisition for most of this year, and the group must submit its decision to Biden before December 22 or 23.ECB: Domestic inflation has dropped slightly, but it is still at a high level. ECB: Staff now expect the economic recovery to be slower than predicted in September. As time goes on, the influence of restrictive monetary policy gradually fades, which should support the recovery of domestic demand. Domestic inflation has declined slightly, but it is still at a high level, mainly because wages and prices in some industries are still being adjusted to adapt to the past inflation surge.

ECB: Financing conditions are relaxing, ECB: Financing conditions are relaxing. However, because monetary policy is still restrictive and past interest rate hikes are still being transmitted to the credit stock, financing conditions are still tightening. Inflation prospect, core inflation and its transmission will determine the interest rate path.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)India imported 841,993 tons of palm oil in November, compared with 845,682 tons in October.